BioDrugs | 2012(26) articles
- Biologic Rheumatoid Arthritis Therapies : Do We Need More Comparative Effectiveness Data?
- Clinical Relevance of Botulinum Toxin Immunogenicity
- Rituximab : Current Status as Therapy for Malignant and Benign Hematologic Disorders
- Targeting the Epidermal Growth Factor Receptor in Solid Tumor Malignancies
- Hyaluronic Acid for the Treatment of Osteoarthritis in all Joints Except the Knee : What is the Current Evidence?
- How Much are Biosimilars Used in Southern Italy? : A Retrospective Analysis of Epoetin Utilization in the Local Health Unit of Messina in the Years 2010–2011
- DTaP5-IPV-Hib Vaccine (Pediacel®)† : Profile Report
- Eculizumab: A Guide to its Use in Paroxysmal Nocturnal Hemoglobinuria